MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancersAnastasia Wyce, Olena Barbash, Jeanne J. Matteo et al.|Oncogenesis|2018Cited by 36
Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugatesStephanie E. Barrett, Steven L. Colletti, Brian Carr et al.|Journal of Controlled Release|2014Cited by 31
Abstract 4709: Broad activity for the combination of BET and MEK inhibitors across solid and hematologic cancersAnastasia Wyce, Olena Barbash, Daniel Felitsky et al.|Cancer Research|2016Cited by 0